UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non-enzymatic roles of human RAD51 at stalled replication forks

Nature communications, 2019-09, Vol.10 (1), p.4410-11, Article 4410

2019

Volltextzugriff (PDF)

Molecular Targeting of Gene Therapy and Radiotherapy

Acta oncologica, 2001, Vol.40 (6), p.735-738

2001

Volltextzugriff (PDF)

The inherent cellular radiosensitivity of epithelial ovarian carcinoma

Gynecologic oncology, 1989-12, Vol.35 (3), p.282-285

1989

Volltextzugriff (PDF)

Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis

PloS one, 2018-04, Vol.13 (4), p.e0195149

2018

Volltextzugriff (PDF)

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

Clinical cancer research, 2015-02, Vol.21 (3), p.632-641

2015

Volltextzugriff (PDF)

interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2008-11, Vol.105 (47), p.18490-18495

2008

Volltextzugriff (PDF)

Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis

PLoS computational biology, 2010-04, Vol.6 (4), p.e1000730-e1000730

2010

Volltextzugriff (PDF)

Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner

PloS one, 2012-01, Vol.7 (1), p.e29653-e29653

2012

Volltextzugriff (PDF)

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Clinical cancer research, 2015-02, Vol.21 (4), p.870-881

2015

Volltextzugriff (PDF)

Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing

The Journal of immunology (1950), 2013-06, Vol.190 (11), p.5874-5881

2013

Volltextzugriff (PDF)

p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability

Nature communications, 2020-10, Vol.11 (1), p.5007-5007, Article 5007

2020

Volltextzugriff (PDF)

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease

Cancer, 2012-06, Vol.118 (11), p.2962-2970

2012

Volltextzugriff (PDF)

RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation

Proceedings of the National Academy of Sciences - PNAS, 2014-01, Vol.111 (4), p.E484-E491

2014

Volltextzugriff (PDF)

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

BMC genomics, 2010-05, Vol.3 (1), p.16-16, Article 16

2010

Volltextzugriff (PDF)

Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial

Clinical cancer research, 2020-12, Vol.26 (24), p.6437-6444

2020

Volltextzugriff (PDF)

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

PloS one, 2009-06, Vol.4 (6), p.e5821-e5821

2009

Volltextzugriff (PDF)

Combined effects of angiostatin and ionizing radiation in antitumour therapy

Nature (London), 1998-07, Vol.394 (6690), p.287-291

1998

Volltextzugriff (PDF)

Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation

Cancer research (Chicago, Ill.), 1999-07, Vol.59 (14), p.3374-3378

1999

Volltextzugriff (PDF)

Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors

Clinical cancer research, 2021-10, Vol.27 (20), p.5510-5518

2021

Volltextzugriff (PDF)

Predictors of Competing Mortality in Advanced Head and Neck Cancer

Journal of clinical oncology, 2010-01, Vol.28 (1), p.15-20

2010

Volltextzugriff (PDF)

Two decades of advances in clinical oncology — lessons learned and future directions

Nature reviews. Clinical oncology, 2024-10, Vol.21 (11), p.771-780

2024

Volltextzugriff (PDF)

MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment

Proceedings of the National Academy of Sciences - PNAS, 2009-04, Vol.106 (14), p.5837-5841

2009

Volltextzugriff (PDF)

Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors

Cancer research (Chicago, Ill.), 2010-08, Vol.70 (15), p.6277-6282

2010

Volltextzugriff (PDF)

DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer

PloS one, 2014-07, Vol.9 (7), p.e102112

2014

Volltextzugriff (PDF)

Phase I Study of Bevacizumab Added to Fluorouracil- and Hydroxyurea-Based Concomitant Chemoradiotherapy for Poor-Prognosis Head and Neck Cancer

Journal of clinical oncology, 2008-04, Vol.26 (10), p.1732-1741

2008

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(177)

Publikationsform

Artikel
(198)
Buchkapitel
(1)

Sprache

Englisch
(199)

Erscheinungsjahr

n.n

Thema

Science & Technology
(144)
Humans
(142)
Life Sciences & Biomedicine
(129)
Oncology
(98)
Biological And Medical Sciences
(90)
Medical Sciences
(79)
Female
(76)
Male
(54)
Tumors
(54)
Middle Aged
(49)
Animals
(48)
Combined Modality Therapy
(43)
Adult
(42)
Aged
(39)
Mice
(34)
Pharmacology. Drug Treatments
(32)
Antineoplastic Agents
(31)
Head And Neck Neoplasms - Drug Therapy
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)
Tumor Cells, Cultured
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Non-enzymatic roles of human RAD51 at stalled replication forks

Molecular Targeting of Gene Therapy and Radiotherapy

The inherent cellular radiosensitivity of epithelial ovarian carcinoma

Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis

Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing

p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease

RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

Combined effects of angiostatin and ionizing radiation in antitumour therapy

Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation

Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors

Predictors of Competing Mortality in Advanced Head and Neck Cancer

Two decades of advances in clinical oncology — lessons learned and future directions

MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment

Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors

DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer

Phase I Study of Bevacizumab Added to Fluorouracil- and Hydroxyurea-Based Concomitant Chemoradiotherapy for Poor-Prognosis Head and Neck Cancer

Suchergebnisse filtern